Skip to main content
. 2017 Jul 5;8(59):100478–100489. doi: 10.18632/oncotarget.19001

Table 1. Main characteristics of studies included in the meta-analysis.

Study Country Number of patients Sex Median age TNM stage Deep of invasion LN metastasis Vascular invasion Lymphatic invasion Histological type Size Detection method HMGA2-positive ratio(%) Survival data type Quanlity score
HMGA2+vs
HMGA2-
Male/
female
I+II/III+IV T1+T2/
T3+T4
Present/
absent
Present/
absent
Present/
absent
Well+moderately/ poorly >3cm/
<=3cm
Dequan et al. (2014) China 158
68vs90
104/54 NR 57/101 86/72 93/65 61/97 NR 117/41 63/95 IHC 43.0 OS 7
Junhy et al. (2015) Korea 170
39vs131
123/47 61.5(29-89) 75/96 35/135 105/65 19/151 136/34 51/119 NR IHC 22.9 OS 7
Kazuo et al. (2008) Japan 110
55vs55
72/38 NR 59/51 67/43 78/32 30/80 78/32 55/55 87/23 IHC 50.0 OS 7
Kyong-Hwa et al. (2015) Korea 110
72vs38
67/43 63.7(NR) 59/51 33/77 73/37 22/88 68/42 57/53 NR IHC 65.5 DFS 7
LV Bonan et al. (2014) China 93
68vs25
56/37 54(39-76) 26/67 33/60 55/38 NR NR NR NR IHC 73.1 OS 8
ZHA Lang et al. (2011) China 71
46vs27
45/26 53(29-81) 25/46 NR 49/22 NR NR 29/42 48/32 IHC 64.8 NR 6

Abbreviations: DFS=disease free survival, IHC = immunohistochemistry, LN= Lymph node, NA= not available, OS=overall survival.